The effects of breast density on the benefits of mammograms with adjunctive ultrasonography in breast screening.
Breast cancer screening
Breast density
Mammography
Ultrasonography
Journal
Breast cancer (Tokyo, Japan)
ISSN: 1880-4233
Titre abrégé: Breast Cancer
Pays: Japan
ID NLM: 100888201
Informations de publication
Date de publication:
28 Nov 2023
28 Nov 2023
Historique:
received:
26
09
2023
accepted:
06
11
2023
medline:
28
11
2023
pubmed:
28
11
2023
entrez:
27
11
2023
Statut:
aheadofprint
Résumé
Various efforts have been made to improve the accuracy of breast cancer screening. This study aimed to report differences in the contribution of ultrasonography to cancer screening assessments of dense and non-dense breasts. The participants in this study were 29,640 Japanese women in their 40 s who underwent breast cancer screening at the Iwate Cancer Society between 2018 and 2021. This included women who chose mammography alone or mammography with adjunctive ultrasonography (overall assessment). They were classified into two groups according to the breast density in mammography: dense breasts and non-dense breasts. Recall rate, breast cancer detection rate, and positive predictive value of the two screening-type groups were evaluated for each breast density group. Of the 29,640 women analyzed, 18,861 (63.6%) underwent mammography alone and 10,779 (36.3%) were by overall assessments. The number of women recalled was higher in the overall assessment group than in the mammography-alone group (2.9% vs. 1.9%, p < 0.01). The proportion of women in whom breast cancer was detected was higher in the overall assessment group than in the mammography-alone group (0.31% [n = 33] vs. 0.15% [n = 28], p < 0.01). For non-dense breasts, there were no significant differences in either the recall rate or the breast cancer detection rate between those who underwent mammography alone and those who underwent overall assessment. Conversely, for dense breasts, the recall rate after mammography alone was lower than that after overall assessment (1.8% vs. 3.8%, p < 0.01), and the breast cancer detection rate was higher after overall assessment than after mammography alone (0.40% vs. 0.18%, p < 0.01). We found the benefits of adjunctive ultrasonography with mammography to differ depending on breast density. This could be used to tailor the selection of screening modalities to individuals.
Identifiants
pubmed: 38012337
doi: 10.1007/s12282-023-01525-7
pii: 10.1007/s12282-023-01525-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to The Japanese Breast Cancer Society.
Références
Maskarinec G, Pagano I, Chen Z, Nagata C, Gram IT. Ethnic and geographic differences in mammography density and their association with breast cancer incidence. Breast Cancer Res Treat. 2007;104:47–56.
doi: 10.1007/s10549-006-9387-5
pubmed: 17009106
Suzuki A, Kuriyama S, Kawai M, Amari M, Takebe M, Ishida T, et al. Age-specific interval breast cancers in Japan: estimation of the proper sensitivity of screening using a population-based cancer registry. Cancer Sci. 2008;99:2264–7.
doi: 10.1111/j.1349-7006.2008.00926.x
pubmed: 18795941
Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L, U.S. Preventive services Task Force. Screening for breast cancer; an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151(10):727–37.
doi: 10.7326/0003-4819-151-10-200911170-00009
pubmed: 19920273
pmcid: 2972726
Hori M, Matsuda T, Shibata A, Katanoda K, Sobue T, Nishimoto H, Japan Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2015;45(9):884–91.
doi: 10.1093/jjco/hyv088
pubmed: 26142437
Ohuchi N, Ishida T, Kawai M, Narikawa Y, Yamamoto S, Sobue T. Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40–49 (J-START): research design. Jpn J Clin Oncol. 2011;41(2):275–7.
doi: 10.1093/jjco/hyq214
pubmed: 21131295
Ishida T, Suzuki A, Kawai M, Narikawa Y, Saito H, Yamamoto S, et al. A randomized controlled trial to verify the efficacy of the use of ultrasonography in breast cancer screening aged 40–49 (J-START): 76 196 women registered. Jpn J Clin Oncol. 2014;44(2):134–40.
doi: 10.1093/jjco/hyt199
pubmed: 24407835
Ohuchi N, Suzuki A, Sobue T, Kawai M, Yamamoto S, Zheng YF, J-START Investigator Groups, et al. Sensitivity and specificity of mammography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomized controlled trial. Lancet. 2016;387(10016):341–8.
doi: 10.1016/S0140-6736(15)00774-6
pubmed: 26547101
Ohnuki K, Tsunoda H, Tohno E, Iisato U, Powa M, Obane N, The Study Group for Breast Cancer Screening in Japan Association of Breast and Thyroid Sonology, et al. The criteria for mammography screening combined with ultrasonography. Jpn Assoc Breast Cancer Screen. 2012;21(3):273–9.
doi: 10.3804/jjabcs.21.273
Ohnuki K, Tohno E, Tsunoda H, Uematasu T, Nakajima Y. Overall assessment system of combined mammography and ultrasound for breast cancer screening. Breast Cancer. 2021;28:254–62.
doi: 10.1007/s12282-020-01203-y
pubmed: 33389614
The combined Assessment Committee of the Japan Association of Breast Cancer Screening. The overall assessment manual for combined screening of mammography and ultrasound. Tokyo: Shinoharashinsha; 2015.
Ohnuki K, Tsunoda H, Tohno E, Iisato U, Oiwa M, Obane N, The Study Group for Breast Cancer Screening in Japan Association of Breast and Thyroid Sonology, et al. The criteria for mammography screening combined with ultrasonography (Japanese). Tokyo: Shinoharashinsha; 2015.
Uematsu T, Oiwa M, Okanami Y, Tohno E, Noma M, Miyagi Y. What is the difference of combined assessment with mammography and ultrasound between breast cancer screening and diagnostic breast imaging examination? Jpn Assoc Breast Cancer Screen. 2018;27(2):119–24.
doi: 10.3804/jjabcs.27.119
Suzuki S, Tsunoda H, Kawakami M, Hasegawa H, Yonetsu K, Oyama Y, et al. Evaluation of the recall criteria for breast cancer screening combined with mammography and ultrasonography. Jpn Assoc Breast Cancer Screen. 2013;22(1):115–22.
doi: 10.3804/jjabcs.22.115
Souma A, Ohnuki K, Usami S, Miura Y, Sasaki K, Sekimura N, et al. Practice of overall assessment of breast cancer screening combined with mammography and ultrasonography. Jpn Assoc Breast Cancer Screen. 2016;25(2):160–2.
doi: 10.3804/jjabcs.25.160
Ito N, Yoshimura R, Mori T, Nagano Y, Kamei A, Sou E, et al. Study on breast density-focused breast cancer screening combining mammography and ultrasonography. Ningen Dock. 2017;32:469–75.
Usami S, Ohnuki K, Watanabe M, Umemura A, Takagi M, Asano S, et al. Current status and problems of simultaneous screening with mammography and ultrasound. Jpn Assoc Breast Cancer Screen. 2018;27(1):51–5.
doi: 10.3804/jjabcs.27.51
Japan Radiology Society/Japan Society of Radiological Technology. Mammography guideline. Tokyo: Igaku-Shoin Ltd; 2021.
Tohno E, Umemoto T, Sasaki K, Morishima I, Ueno E. Effect of adding screening ultrasonography to screening mammography on patient recall and cancer detection rates; a retrospective study in Japan. Eur J Radiol. 2013;82:1227–30.
doi: 10.1016/j.ejrad.2013.02.007
pubmed: 23465737
Harada-Shoji N, Suzuki A, Ishida T, Zheng YF, Narikawa-Shiono Y, Sato-Tadano A, et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40–49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2021;4(8): e2121505.
doi: 10.1001/jamanetworkopen.2021.21505
pubmed: 34406400
pmcid: 8374606
National Cancer Center: https://ganjoho.jp/reg_stat/statistics/stat/screening/process-indicator.html . 20 Aug 2023
Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367:1998–2005.
doi: 10.1056/NEJMoa1206809
pubmed: 23171096
Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomized screening trial. BMJ. 2014;348: g366.
doi: 10.1136/bmj.g366
pubmed: 24519768
pmcid: 3921437
Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP. Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. BMJ. 2006;332(7543):689–92.
doi: 10.1136/bmj.38764.572569.7C
pubmed: 16517548
pmcid: 1410836
Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012;380(9855):1778–86.
doi: 10.1016/S0140-6736(12)61611-0
Tadaoki M, Yoshio K, Hiroko T, Tangoku A. Measures for reducing over-diagnosis in breast cancer screening. Jpn Assoc Breast Cancer Screen. 2014;23(3):337–46.
doi: 10.3804/jjabcs.23.337
Welch HG, Black WC. Using autopsy series to estimate the disease “reservoir” for ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann Intern Med. 1997;127:1023–8.
doi: 10.7326/0003-4819-127-11-199712010-00014
pubmed: 9412284